Added value of OCT for diagnosing recurrent BCC after non-invasive treatment
Completed
- Conditions
- Basal cell carcinomaskin cancer10040900
- Registration Number
- NL-OMON55343
- Lead Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Adult patients (>18 years)
Received non-invasive treatment for superficial BCC
Clinical follow-up within 5 years post-treatment
Exclusion Criteria
Patients unable to sign informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method